Advert - Vifor Pharma

Promotion of Ferinject

For a website which promoted intravenous (IV) iron and was linked to the promotion of Ferinject (ferric carboxymaltose) and which was not sufficiently complete for the recipient to form their own opinion of the therapeutic value of the medicines, included a misleading comparison with oral iron and did not have the required obligatory information, Vifor was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Clause 4.1 - Failing to include prescribing information

Clause 4.6 - Failing to include a clear, prominent statement as to where prescribing information could be found

Clause 4.9 - Failing to include information about how to report adverse events

Clause 7.2 - Making a misleading claim

Clause 7.3 - Making misleading comparisons

Clause 9.1 - Failing to maintain high standards

Clause 14.1 - Failing to certify promotional material

 

Advert March 2021